Olaparib in platinum-sensitive ovarian cancer

N Engl J Med. 2012 Jul 12;367(2):179; author reply 179-80. doi: 10.1056/NEJMc1205423.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Maintenance Chemotherapy*
  • Neoplasm Recurrence, Local / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Phthalazines / therapeutic use*
  • Piperazines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Phthalazines
  • Piperazines